Clinical trials
Active, not recruiting Phase 2 Dermatitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 2 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aclaris Therapeutics, Inc. | 1 |
| Kari Nadeau, MD, PhD | 1 |
| Q32 Bio Inc. | 1 |
| Technical University of Munich | 1 |
| Zura Bio Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dermatitis | 5 |
| Dermatitis, Atopic | 2 |
| Eczema | 2 |
| Skin Diseases | 2 |
| Acne Vulgaris | 1 |
| Alopecia | 1 |
| Alopecia Areata | 1 |
| Food Hypersensitivity | 1 |
| Hidradenitis | 1 |
| Hidradenitis Suppurativa | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.